[Paris, France – May 2022]
We’re excited to announce that Plantibodies has been selected to join the WILCO HealthTech program, one of France’s leading innovation accelerators supporting high-potential startups in healthcare.
WILCO is a nonprofit accelerator backed by Île-de-France Region and major industry partners. Its mission: help startups reach their first €1M in revenue within 3 years, by providing intensive coaching, expert mentoring, access to a vast network of corporates and investors, and tailored financial support including a “prêt d’honneur” loan to fuel early growth.
Plantibodies joins a new cohort of 16 health-focused startups across E-Health, Biotech & SmartPharma, MedTech, and Silver Economy & HandiTech. Selected from over 60 applications, the program gives us the opportunity to scale our breakthrough plant based biologics platform within a dynamic ecosystem of innovators and healthcare leaders.
“Becoming part of WILCO is a fantastic milestone for us,” says Pierre Bauër, CEO & co-founder of Plantibodies. “It connects us to a unique ecosystem of entrepreneurs, mentors, and corporates, and gives us the resources to accelerate the translation of our science into tangible healthcare solutions.”
We’re looking forward to this journey, and to advancing our mission of making biologics more accessible, precise, and sustainable.